Thus, PDTC treatment reversed pain sensitivity and downregulated Scn9a and Scn10a, demonstrating that NF-κB contributes to pain hypersensitivity through regulating expression of Scn9a and Scn10a in DRGs of SMA mice. This evidence concerns the gene NFKB1 and proximal spinal muscular atrophy.